{"id":398851,"date":"2020-12-14T08:03:23","date_gmt":"2020-12-14T13:03:23","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=398851"},"modified":"2020-12-14T08:03:23","modified_gmt":"2020-12-14T13:03:23","slug":"aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/","title":{"rendered":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service"},"content":{"rendered":"<div class=\"mw_release\">\n<p>\n        <i>Service Availability is Expected in January 2021<\/i>\n      <\/p>\n<p>MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec.  14, 2020  (GLOBE NEWSWIRE) &#8212; via <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=IaStsqULpaVY5mVHCh6hxXceBjXGR3-N-rMkCLlsYd3WuswlceZr2vTJ_vEGB6ZHHKnCrgvBrZtRubrCZrwjSQ==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">NewMediaWire<\/a> \u2013 Aditx Therapeutics, Inc. (Aditxt) (the \u201cCompany\u201d) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, and Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer\u2019s disease, today announced the signing of a distribution agreement for AditxtScore\u2122 for COVID-19, with planned availability in January 2021.\u00a0<\/p>\n<p>Todos Medical has secured the rights to distribute AditxtScore\u2122 for COVID-19 to monitor immunity against SARS-CoV-2. Blood samples will be collected by Todos and\/or its network of partners and sent to Aditxt\u2019s CLIA accredited AditxtScore\u2122 Center for processing.\u00a0<\/p>\n<p>Amro Albanna, Co-founder and CEO of Aditxt, commented, \u201cThis agreement marks a milestone for AditxtScore\u2122 and Aditxt as a whole. Todos Medical is Aditxt\u2019s first commercial customer for our proprietary AditxtScore\u2122 immune monitoring platform and its first application, AditxtScore\u2122 for COVID-19. As the availability of COVID-19 vaccines increases, the need to understand an individual\u2019s immune profile to measure its effectiveness, increases as well. We look forward to working with the team at Todos and providing our innovative AditxtScore\u2122 platform as a complement to the suite of testing solutions that they offer.\u201d<\/p>\n<p>Gerald Commissiong, President and CEO of Todos Medical, added, \u201cAfter a thorough review of the immune-related COVID-19 testing market, we believe that Aditxt\u2019s platform technology represents a unique multidimensional view of the immune system that will be critical to allow physicians and scientists to categorize immune responses to vaccines and therapeutic approaches for COVID-19 in order to determine which interventions to use for which patients in a personalized way. As vaccines for COVID-19 are rolled out, it is imperative that we evaluate patients\u2019 immune status prior to and after vaccination, and track when immunity is gained and how long it might last with repeat immune testing. The AditxtScore\u2122 for COVID-19 scoring system will initially include antibody and neutralizing antibodies, and will soon include T-cell and B-cell responses as well, which makes it the most comprehensive immune profiling tool for COVID-19 available in the market.\u201d<\/p>\n<p>\n        <b>About Aditx Therapeutics<\/b>\n      <\/p>\n<p>Aditxt is developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming. The immune monitoring biotechnology is designed to provide a personalized comprehensive profile of the immune system. The immune reprogramming biotechnology is currently at the pre-clinical stage and is designed to retrain the immune system to induce tolerance with an objective of addressing rejection of transplanted organs, autoimmune diseases, and allergies. For more information, please visit: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=o6lxlJzRRm_xduebLyqzSl1xxNPyngOsvBSnFxxqOh9QMltjW-VkRE-mhr_VZdrDHJ4bJRaBZhFVmiYIutv13A==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.aditxt.com<\/a> and www.aditxtscore.com<\/p>\n<p>\n        <b>About Todos Medical Ltd.<\/b>\n      <\/p>\n<p>Headquartered in Rehovot, Israel, Todos Medical Ltd. (OTCQB: TOMDF) engineers life-saving diagnostic solutions for the early detection of a variety of cancers. The Company&#8217;s state-of-the-art and patented Todos Biochemical Infrared Analyses (TBIA) is a proprietary cancer-screening technology using peripheral blood analysis that deploys deep examination into cancer&#8217;s influence on the immune system, looking for biochemical changes in blood mononuclear cells and plasma. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=g_h8b7_BamcrOavl0fgGh93BbhiVRlE85_OSxc8J6q709pEVfNO8_uC_OxCzDYQilbGZkyrQET3OMJm9TxmHhlU7ix_I0pc5OykYywxR4Uib2kpw-_yjKavx8Ol-CcAN\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.todosmedical.com\/.<\/a><\/p>\n<p>\n        <b>Forward-Looking Statements<\/b>\n      <\/p>\n<p>Certain statements in this press release constitute \u201cforward-looking statements\u201d within the meaning of the federal securities laws. Forward-looking statements include statements regarding the Company\u2019s intentions, beliefs, projections, outlook, analyses or current expectations concerning, among other things, the Company\u2019s ongoing and planned product development; the Company\u2019s intellectual property position; the Company\u2019s ability to develop commercial functions; expectations regarding product launch and revenue; the Company\u2019s results of operations, cash needs, spending, financial condition, liquidity, prospects, growth and strategies; the industry in which the Company operates; and the trends that may affect the industry or the Company. Forward-looking statements are not guarantees of future performance and actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, as well as those risks more fully discussed in the section entitled \u201cRisk Factors\u201d in the Company\u2019s prospectus, dated September 1, 2020, that was filed with the Securities and Exchange Commission under File No. 333-248491, as well as discussions of potential risks, uncertainties, and other important factors in the Company\u2019s subsequent filings with the Securities and Exchange Commission. All such statements speak only as of the date made, and the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n<p>\n        <b>Aditxt Investor Relations:<\/b><br \/>\n        <br \/>PCG Advisory<br \/>Jeff Ramson<br \/>Chief Executive Officer<br \/>646-863-6341<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_LqmhBZ11Q7DtOyEjkejYRCgwwOnH5ivtVJOBOWWSvChGr2fMFH9LWHZuHrqG6Bpl-1NWgAlYcuRyNQZ9c0c9w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">IR@aditxt.com<\/a><\/p>\n<p>\n        <b>Todos Investor Relations:<\/b><br \/>\n        <br \/>Kim Sutton Golodetz<br \/>LHA Investor Relations<br \/>Senior Vice President<br \/>(212) 838-3777<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=GA7qpl7Z3toXMa1Yq-2L8Wr-sE646lTLgzF2HWLNTEjSjJIPirc6Bf-9hoQnQ_p-NuCRgCQaznmbJE1kq0vh7Ez0keZLvqsUJzYh93qPg6Y=\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">kgolodetz@lhai.com<\/a><\/p>\n<p>\n        <b>Todos Corporate Contact:<\/b><br \/>\n        <br \/>Priyanka Misra<br \/>Todos Medical<br \/>(917) 983-4229 ext. 103<br \/>priyanka@todosmedical.com<\/p>\n<p \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ed30f54d-d157-4c08-84eb-a3fb860a9a32\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) &#8212; via NewMediaWire \u2013 Aditx Therapeutics, Inc. (Aditxt) (the \u201cCompany\u201d) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, and Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer\u2019s disease, today announced the signing of a distribution agreement for AditxtScore\u2122 for COVID-19, with planned availability in January 2021.\u00a0 Todos Medical has secured the rights to distribute AditxtScore\u2122 for COVID-19 to monitor immunity against SARS-CoV-2. Blood samples &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-398851","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) &#8212; via NewMediaWire \u2013 Aditx Therapeutics, Inc. (Aditxt) (the \u201cCompany\u201d) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, and Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer\u2019s disease, today announced the signing of a distribution agreement for AditxtScore\u2122 for COVID-19, with planned availability in January 2021.\u00a0 Todos Medical has secured the rights to distribute AditxtScore\u2122 for COVID-19 to monitor immunity against SARS-CoV-2. Blood samples &hellip; Continue reading &quot;Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-14T13:03:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service\",\"datePublished\":\"2020-12-14T13:03:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/\"},\"wordCount\":810,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/\",\"name\":\"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\",\"datePublished\":\"2020-12-14T13:03:23+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/","og_locale":"en_US","og_type":"article","og_title":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk","og_description":"Service Availability is Expected in January 2021 MOUNTAIN VIEW, CA and REHOVOT, ISRAEL, Dec. 14, 2020 (GLOBE NEWSWIRE) &#8212; via NewMediaWire \u2013 Aditx Therapeutics, Inc. (Aditxt) (the \u201cCompany\u201d) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, and Todos Medical Ltd. (OTCQB: TOMDF), an in vitro diagnostics company focused on distributing comprehensive solutions for COVID-19 screening and diagnosis, and developing blood tests for early detection of cancer and Alzheimer\u2019s disease, today announced the signing of a distribution agreement for AditxtScore\u2122 for COVID-19, with planned availability in January 2021.\u00a0 Todos Medical has secured the rights to distribute AditxtScore\u2122 for COVID-19 to monitor immunity against SARS-CoV-2. Blood samples &hellip; Continue reading \"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-14T13:03:23+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service","datePublished":"2020-12-14T13:03:23+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/"},"wordCount":810,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/","name":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==","datePublished":"2020-12-14T13:03:23+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMTQ3OCMzODc5NDk0IzUwMDA3Mjc5NA=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aditxt-signs-distribution-agreement-with-todos-medical-ltd-for-aditxtscore-for-covid-19-immune-monitoring-service\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aditxt Signs Distribution Agreement with Todos Medical Ltd. For AditxtScore\u2122 for COVID-19 Immune Monitoring Service"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398851","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=398851"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/398851\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=398851"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=398851"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=398851"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}